Delivery Order SPE2DB22D3301-SPE2DB24FZ2LY

Award Date 8/8/24
Potential Completion Date 8/9/24
Potential Value $1.6K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract worth $1,416.59 to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to provide the pharmaceutical product LO LOESTRIN FE 1-10 TABLET 28S. This delivery order is part of a larger indefinite delivery contract (IDC) valued up to $999,999,999.00 that was awarded solely to AmerisourceBergen Drug Corp by DLA to supply a range of pharmaceutical products and medical supplies to DLA Troop...
The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the delivery of LO LOESTRIN FE 1-10 TABLET 28S pharmaceuticals. The $11,296.96 contract has a completion date of February 7, 2024 and is not set-aside. Amerisourcebergen Drug Corp is the prime contractor on this delivery order as well as an indefinite delivery contract (IDC) valued up to $999,999,999.00 with DLA Troop Support Medical to...
This is a $26,844.44 firm-fixed price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp's Corporate Office division. The contract is for the supply of LO LOESTRIN FE 1-10 TABLET 28S pharmaceutical products, with a performance period ending on September 17, 2024. The contract has no set-aside designation. AmerisourceBergen Drug Corp is a major pharmaceutical distributor that holds several Indefinite Delivery Contracts (IDCs) with federal agencies,...
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,620.69 firm fixed-price delivery order contract is for the supply of LO LOESTRIN FE 1-10 TABLET 28S, a pharmaceutical product. The contract has an ultimate completion date of October 11, 2023 and is not designated under any set-aside program. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC)...
This is a $12,977.10 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of LO LOESTRIN FE 1-10 TABLET 28S, a pharmaceutical product. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of LO LOESTRIN FE 1-10 tablets. The contract has a firm fixed-price of $2,211.02 and runs through July 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to provide a comprehensive range of pharmaceutical products and medical supplies to support military healthcare...
This is a $2,592.07 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of LO LOESTRIN FE 1-10 TABLET 28S, a pharmaceutical product. This delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, which serves as the primary...
This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The contract is for the delivery of LO LOESTRIN FE 1-10 TABLET 28S, a pharmaceutical product, with a ceiling value of $10,283.69 and a period of performance through April 12, 2024. The contract is a firm fixed price delivery order, and no set-aside...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of the pharmaceutical product LO LOESTRIN FE 1-10 TABLET 28S, with a firm fixed price ceiling value of $1,411.78. The contract has a performance period through May 23, 2025. AmerisourceBergen Drug Corp holds a larger $999,999,999.00 Indefinite Delivery Contract (IDC) with the...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,787.65 firm fixed-price contract is for the delivery of LO LOESTRIN FE 1-10 TABLET 28S, a prescription medication. The contract has an ultimate completion date of June 25, 2025. Amerisourcebergen Drug Corp is the prime contractor on this order, which is not designated as a set-aside. The company also holds a...
  • SPE2DB22D3301
    Indefinite Delivery Contract
  • SPE2DB22D3301-SPE2DB24FZ2LY
    Delivery Order

The U.S. Defense Logistics Agency (DLA) awarded a firm-fixed-price delivery order contract to AmerisourceBergen Drug Corp's Corporate Office division, a major pharmaceutical distributor, for the supply of LO LOESTRIN FE 1-10 TABLET 28S. The $1,647.36 contract has an ultimate completion date of August 9, 2024. AmerisourceBergen, a for-profit organization, holds multiple Indefinite Delivery Contracts (IDCs) with DLA Troop Support Medical and the Department of Justice Federal Bureau of Investigation, valued at up to $999,999,999 and $750,000 respectively, for providing a wide range of pharmaceutical and medical supplies to support federal healthcare programs. This specific delivery order does not have a set-aside designation.

Generated 11/7/24, 9:22 AM